Christoph Male Selected Research

Christoph Male Research Topics

Disease

18	Hemophilia A (Haemophilia) 11/2023 - 05/2009
17	Hemorrhage 12/2023 - 09/2013
15	Thrombosis (Thrombus) 03/2023 - 06/2003
10	Venous Thromboembolism 11/2022 - 01/2018
6	Venous Thrombosis (Deep-Vein Thrombosis) 02/2022 - 01/2007
5	Heart Failure 12/2023 - 01/2019
4	Thromboembolism 12/2023 - 01/2007
3	Hemophilia B (Haemophilia B) 01/2024 - 09/2016
3	Congenital Heart Defects (Congenital Heart Defect) 05/2022 - 01/2019
3	Epilepsy (Aura) 11/2021 - 01/2020
2	Heart Diseases (Heart Disease) 12/2023 - 11/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2022 - 09/2019
2	COVID-19 related pediatric multisystem inflammatory disease 01/2022 - 11/2020
2	Drug Resistant Epilepsy 11/2021 - 08/2020
2	Ketosis 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 11/2015
2	Infantile Spasms (West Syndrome) 10/2019 - 01/2019
2	Sepsis (Septicemia) 12/2005 - 02/2004
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 12/2023
1	Type I Plasminogen Deficiency 12/2023
1	Hydrocephalus (Hydrocephaly) 12/2023
1	Pathologic Constriction (Stenosis) 12/2023
1	Hypersensitivity (Allergy) 01/2023
1	Osteoporosis 01/2023
1	Pain (Aches) 01/2023
1	Neoplasms (Cancer) 11/2022
1	Thrombocytopenia (Thrombopenia) 11/2022
1	Infections 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Critical Illness (Critically Ill) 10/2021
1	Vomiting 10/2021
1	Nausea 10/2021
1	Gastroenteritis 10/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021
1	Thrombotic Microangiopathies 12/2020
1	Joint Diseases (Joint Disease) 11/2020
1	COVID-19 11/2020
1	Hypertension (High Blood Pressure) 08/2020
1	Chronic Renal Insufficiency 08/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020

Drug/Important Bio-Agent (IBA)

16	AnticoagulantsIBA 03/2023 - 12/2005
13	Factor VIII (Coagulation Factor VIII)IBA 11/2023 - 05/2009
11	RivaroxabanIBA 11/2022 - 01/2018
6	Vitamin K FDA Link 12/2023 - 10/2019
5	AntibodiesIBA 02/2015 - 12/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2023 - 10/2019
4	Enalapril FDA LinkGeneric 12/2023 - 09/2019
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 01/2019
3	Recombinant Fusion ProteinsIBA 01/2024 - 09/2016
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2024 - 09/2016
3	AlbuminsIBA 01/2024 - 09/2016
3	AntithrombinsIBA 01/2023 - 04/2010
3	Prothrombin (Factor II)IBA 12/2020 - 01/2007
3	Neutralizing AntibodiesIBA 05/2016 - 02/2013
3	Antiphospholipid AntibodiesIBA 10/2011 - 12/2005
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2020
2	apixabanIBA 12/2023 - 11/2019
2	A-factor (Streptomyces)IBA 12/2023 - 01/2023
2	recombinant factor VIII N8IBA 11/2023 - 01/2023
2	Hemostatics (Antihemorrhagics)IBA 11/2023 - 01/2023
2	emicizumabIBA 09/2023 - 12/2020
2	Dabigatran FDA Link 02/2022 - 09/2021
2	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2021 - 01/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 02/2015 - 01/2007
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	Protein CIBA 12/2005 - 02/2004
1	Factor Xa InhibitorsIBA 12/2023
1	ReninIBA 12/2023
1	PlasminogenIBA 12/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	OsteocalcinIBA 01/2023
1	Enalaprilat (Vasotec)FDA LinkGeneric 05/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	TroponinIBA 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 10/2021
1	N(4)-oleylcytosine arabinosideIBA 09/2021
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	fibrin fragment D (D-dimer)IBA 11/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	CarbohydratesIBA 01/2020
1	SuspensionsIBA 01/2020
1	TabletsIBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2024 - 02/2013
6	Ketogenic Diet 11/2021 - 01/2019
6	Catheters 10/2020 - 11/2015
2	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2019
2	Injections 04/2020 - 09/2016
1	Ventriculoperitoneal Shunt 12/2023
1	Treatment Delay 12/2023
1	Secondary Prevention 02/2022
1	Off-Label Use 10/2021
1	Parenteral Nutrition 01/2021
1	Contraindications 11/2020
1	Central Venous Catheters 10/2020
1	Splenectomy 01/2020